Dualogics
Chapel Hill
About Dualogics
Dualogics is a biotechnology company housed at the University of North Carolina at Chapel Hill. Dualogics uses a proprietary bispecific antibody technology to create bispecific antibody products with superior properties compared to alternative methods. Our goal is to collaborate with academic and industrial partners to develop and test a suite of multifunctional therapies and reagents.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $250.0K
- Last round: Debt Financing (Dec 2018)
- Website: dualogics.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/dualogics-166508 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.